• Home Dutch
  •  EN 
  • Employee login

Identification of kinomic key proteins involved in tachycardia and stretch induced cardiomyocyte remodeling.

Print 

Title: Identification of kinomic key proteins involved in tachycardia and stretch induced cardiomyocyte remodeling
Investigator:  RAM Meijering
Promotor:  RH Henning
Co-promoter(es):  BJJM Brundel
Summary:  This PhD program is directed at the identification of the kinomic key proteins underlying the induction of early myocyte remodeling during tachypacing and stretch. This knowledge will be very useful in the development of additional, novel interventions directed at counteracting the key proteins, resulting in prevention of early remodeling and conservation of the myocyte function.

Employment of in vitro cell-models for cardiac diseases will gain new insight into the interplay of the various factors involved in different aspects of early myocyte remodeling. A new cell-model system to study stretch induced myocyte remodeling is clinically highly relevant, since stretch is of interest as it occurs in the atrium during heart failure and hypertension which are the most frequent precursors of AF. Increasing knowledge on stretch induced remodeling may ultimately lead to prevention of AF

Financing: Dutch Heart Foundation 2007B217
Start: 1-06-2008
End: 2-06-2014

Projects
Organ damage and the role of CBS in hibernation.
Mechanisms and modulation of the immune response in sterile sepsis.
The CBS/H2S pathway in the brain.
Platelet dynamics in natural and pharmacologically induced hibernation.
Liver fibrosis and hibernation.
Towards prevention of neuroinflammation in major surgery.
Limiting the impact of stroke.
Identification of kinomic key proteins involved in tachycardia and stretch induced cardiomyocyte remodeling.
Role of epigenetic regulation by histone acetylation in the induction of Atrial Fibrillation.
Reversal of cardiomyocyte remodeling in Atrial Fibrillation; the role of protein degradation and translation modulators.
REVersal of cardiomyocyte structural remodeling and Improvement of functional recoVEry in Atrial Fibrillation: REVIVE.
HSF1 Activators Lower cardiomyocyte damage: towards a novel Therapeutic approach to REVERSE Atrial Fibrillation. HALT&REVERSE
Mutations in HSPB5, HSPB7 and BAG3 lead to juvenile DCM.
New therapeutic targets in diabetic kidney disease. A role of GDF-15?
Role of cyclooxygenase signalling on vascular dysfunction in the metabolic syndrome.
Vascular (Dys-)Function as a Determinant of Susceptibility to Diabetic Nephropathy: a Focus on Myogenic Constriction.